Pfizer 2009 Annual Report Download - page 50

Download and view the complete annual report

Please find page 50 of the 2009 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 110

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110

Consolidated Statements of Shareholders’ Equity
Pfizer Inc. and Subsidiary Companies
PFIZER INC. SHAREHOLDERS
PREFERRED
STOCK
COMMON
STOCK ADD’L
PAID-IN
CAPITAL
EMPLOYEE
BENEFIT TRUSTS TREASURY STOCK
RETAINED
EARNINGS
ACCUM.
OTHER
COMP.
INC./(EXP.)
SHARE-
HOLDERS’
EQUITY
NON-
CONTROLL-
ING
INTERESTS
TOTAL
SHARE-
HOLDERS’
EQUITY
(MILLIONS, EXCEPT
PREFERRED SHARES) SHARES
STATED
VALUE SHARES
PAR
VALUE SHARES
FAIR
VALUE SHARES COST
Balance, January 1, 2007 3,497 $141 8,819 $441 $69,104 (30) $(788) (1,695)$(46,740) $49,669 $ (469) $71,358 $ 74 $71,432
Comprehensive income:
Net income 8,144 8,144 42 8,186
Other comprehensive
income, net of tax 2,768 2,768 6 2,774
Total comprehensive income 10,912 48 10,960
Adoption of new accounting
standard—net of tax 11 11 11
Cash dividends declared—
common stock (8,156) (8,156) (8,156)
preferred stock (8) (8) (8)
Stock option transactions 23 1 738 5 121 — (7) 853 853
Purchases of common stock (395) (9,994) (9,994) (9,994)
Employee benefit trust
transactions—net (49) 1 117 68 68
Preferred stock conversions
and redemptions (1,195) (48) (25) 1 5 (68) (68)
Other 8 — 145 — (111) 34 (8) 26
Balance, December 31, 2007 2,302 93 8,850 442 69,913 (24) (550) (2,089) (56,847) 49,660 2,299 65,010 114 65,124
Comprehensive income:
Net income 8,104 8,104 23 8,127
Other comprehensive
expense, net of tax (6,868) (6,868) 35 (6,833)
Total comprehensive income 1,236 58 1,294
Cash dividends declared—
common stock (8,617) (8,617) (8,617)
preferred stock (5) (5) (5)
Stock option transactions 207 1 32 239 239
Purchases of common stock (26) (500) (500) (500)
Employee benefit trust
transactions—net (113) (1) 93 (20) (20)
Preferred stock conversions
and redemptions (498) (20) (7) — 2 (25) (25)
Other 13 1 283 (2) (46) 238 12 250
Balance, December 31, 2008 1,804 73 8,863 443 70,283 (24) (425) (2,117) (57,391) 49,142 (4,569) 57,556 184 57,740
Comprehensive income:
Net income 8,635 8,635 9 8,644
Other comprehensive
income, net of tax 5,121 5,121 5 5,126
Total comprehensive income 13,756 14 13,770
Acquisition of Wyeth 1,319 35,733 (12,430) 23,303 330 23,633
Cash dividends declared—
common stock (4,916) (4,916) (4,916)
preferred stock (5) (5) (5)
Noncontrolling interests — (5) (5)
Stock option transactions 130 — 9 139 139
Purchases of common stock 6 — — —
Employee benefit trust
transactions—net (61) 7 111 50 50
Preferred stock conversions
and redemptions (293) (12) (1) — 3 (10) (10)
Purchase of subsidiary
shares from noncontrolling
interests (66) (66) (102) (168)
Other 212 (2) (28) (1) 23 207 11 218
Balance, December 31,
2009 1,511 $ 61 8,869 $443 $70,497 (19) $(333) (799)$(21,632) $40,426 $ 552 $90,014 $ 432 $90,446
See Notes to Consolidated Financial Statements, which are an integral part of these statements.
48 2009 Financial Report